GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inogen Inc (STU:6IO) » Definitions » Institutional Ownership

Inogen (STU:6IO) Institutional Ownership : 37.42% (As of Jun. 27, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Inogen Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Inogen's institutional ownership is 37.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Inogen's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Inogen's Float Percentage Of Total Shares Outstanding is 98.97%.


Inogen Institutional Ownership Historical Data

The historical data trend for Inogen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inogen Institutional Ownership Chart

Inogen Historical Data

The historical data trend for Inogen can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31
Institutional Ownership 45.80 46.34 45.71 45.72 44.59 44.80 44.75 36.66 37.37 37.42

Inogen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Inogen Business Description

Traded in Other Exchanges
Address
859 Ward Drive, Goleta, CA, USA, 93111
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Inogen Headlines

No Headlines